| Identification | Back Directory | [Name]
Pyrano[2,3-e]isoindole-8(2H)-pentanoic acid, 2-[(3E)-4,8-dimethyl-3,7-nonadien-1-yl]-α-[(2S,3S)-2-[(3E)-4,8-dimethyl-3,7-nonadien-1-yl]-3,4,7,9-tetrahydro-3,5-dihydroxy-2-methyl-7-oxopyrano[2,3-e]isoindol-8(2H)-yl]-3,4,7,9-tetrahydro-3,5-dihydroxy-2-methyl-7-oxo-, (αS,2S,3S)- | [CAS]
733805-92-0 | [Synonyms]
Pyrano[2,3-e]isoindole-8(2H)-pentanoic acid, 2-[(3E)-4,8-dimethyl-3,7-nonadien-1-yl]-α-[(2S,3S)-2-[(3E)-4,8-dimethyl-3,7-nonadien-1-yl]-3,4,7,9-tetrahydro-3,5-dihydroxy-2-methyl-7-oxopyrano[2,3-e]isoindol-8(2H)-yl]-3,4,7,9-tetrahydro-3,5-dihydroxy-2-methyl-7-oxo-, (αS,2S,3S)- | [Molecular Formula]
C51H68N2O10 | [MOL File]
733805-92-0.mol | [Molecular Weight]
869.09 |
| Chemical Properties | Back Directory | [Boiling point ]
1017.5±65.0 °C(Predicted) | [density ]
1.211±0.06 g/cm3(Predicted) | [form ]
Solid | [pka]
3.46±0.21(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Description]
Orniplabin, also known as SMTP-7 is a dual inhibitor of thrombolysis and soluble epoxide hydrolase. SMTP-7 promotes thrombolysis and inhibits soluble epoxide hydrolase. | [Uses]
Orniplabin (SMTP-7) is a low-molecular-weight compound that enhances plasminogen–fibrin binding, urokinase-catalyzed activation of plasminogen, and urokinase and plasminogen-mediated fibrin degradation. Orniplabin shows potential thrombolytic and anti-inflammatory effects. Orniplabin inhibits ROS[1][2]. | [References]
[1] Shibata K, et al. A novel finding of a low-molecular-weight compound, SMTP-7, having thrombolytic and anti-inflammatory effects in cerebral infarction of mice. Naunyn Schmiedebergs Arch Pharmacol. 2010 Sep;382(3):245-53. DOI:10.1007/s00210-010-0542-5
[2] Shibata K, et al. Neuroprotective mechanisms of SMTP-7 in cerebral infarction model in mice. Naunyn Schmiedebergs Arch Pharmacol. 2011 Jul;384(1):103-8. DOI:10.1007/s00210-011-0642-x |
|
|